Management of antipsychotic-induced hyperprolactinaemia

摘要: SUMMARY Hyperprolactinaemia is a common endocrine disorder that can be associated with significant morbidity. Antipsychotic medications are frequently linked to hyperprolactinaemia. This usually presents as menstrual problems in women and sexual men, which affect the patients’ quality of life adherence antipsychotic treatment. In past, treatment for hyperprolactinaemia was recommended only symptomatic patients. However, it has become clear persistent asymptomatic long-term physical morbidities such osteoporosis possibly breast cancer. Hence, imperative managed even if when initially detected. article discusses various management options, reducing dose medication, switching prolactin-sparing adding aripiprazole regimen.